Table 2.
Outcomes and Patient-Rated Instruments
| Instrument name | Purpose | Scale | Score rangea |
|---|---|---|---|
| Clinician-rated instruments | |||
| mAIMS (modified Abnormal Involuntary Movement Scale)5,13 | Assess the severity of abnormal movements in 6 different areas of the body | 5-point scale, with ratings from 0–4 (absent, minimal, mild, moderate, severe), with higher scores indicating more severe abnormal movements |
0–24: Mild = 0–12 Moderate = 13–18 Severe = 19+ |
| UPDRS (Unified Parkinson's Disease Rating Scale)5,12 | Assess the severity of Parkinson's disease symptoms using a 5-point scale with ratings from 0 (normal) to 4 (severe), with higher scores indicating greater disability from Parkinson's disease | The UPDRS is made up of the following sections5,12:
These are evaluated by interview and clinical observation Some sections require multiple grades assigned to each extremity |
This study included only select questions from Part IV (Complications of therapy, questions 32 and 33) |
| Patient-rated instruments | |||
| PDYS-26 (Parkinson Disease Dyskinesia 26-item Scale)5 | Quantify the impact of dyskinesia on ADLs during the past week | 5-point scale, where 0 = not at all and 4 = activity impossible |
0–104: Mild = 0–26 Moderate = 27–52 Severe = 53+ |
| PDQ-39 (39-item Parkinson's Disease Questionnaire)14,15 | Measure health status, covering 8 aspects of quality of life | 5-point scale, where 0 = never and 4 = always |
0–156: Mild = 0–39 Moderate = 40–78 Severe = 79+ |
Mild, moderate, and severe ranges were determined by multiplying the number of questions by the score assigned to that severity (eg, in the PDYS-26, a moderate severity score = 2; therefore 2 * 26 = 52) to determine the maximum score for the moderate range.
ADLs indicates activities of daily living.